Gut bacteria and their metabolites can reach blood vessels, exert local effects in joints, modify macrophage-mediated inflammation and influence GA pain through breaches in the intestinal barrier

Gut bacteria and their metabolites can reach blood vessels, exert local effects in joints, modify macrophage-mediated inflammation and influence GA pain through breaches in the intestinal barrier. (A) LPS activates TLR4 receptors on macrophage membranes and induces IL-1β secretion via the TLR4/NK-κB pathway, causing GA inflammation and pain; (B) SCFAs and LPS affect GA pain by activating or inhibiting the NLRP3 pathway in macrophages, regulating IL-1β release; (C) P2X7R pathway activation following dysbiosis further regulates inflammatory signaling (e.g., the NLRP3 pathway), promoting mature IL-1β secretion and amplifying pain; (D) Complement activation by gut microbes may modulate GA pain by influencing metabolite levels and IL-1β secretion; (E) Gut microbiota may influence the NF-κB pathway by regulating ADPN expression in macrophages, affecting IL-1β maturation and secretion; (F) After MSU enters into macrophages via cytosolic mode, it promotes the conversion of Pro-IL-1β to mature IL-1β through NLRP3/ASC/Caspase-1-mediated inflammatory events.(G) Anti-GA drugs could affect macrophage-mediated GA pain mechanisms by influencing gut microbiota and metabolite concentrations; (H) TCM modulates macrophage immunity and inflammation alleviating GA pain through gut microbes and metabolites; (I) FMT is likely to treat GA pain by affecting BUA levels and inhibiting M1 macrophage polarization via gut microbes; (J) Probiotics reduce GA pain by restoring the intestinal barrier and inhibiting NLRP3 in macrophages, reducing inflammatory factors like IL-1β secretion
Gut bacteria and their metabolites can reach blood vessels, exert local effects in joints, modify macrophage-mediated inflammation and influence GA pain through breaches in the intestinal barrier

Publication

Gut-immunity-joint axis: a new therapeutic target for gouty arthritis (2024) Pei Chen, et al. Front Pharmacol. 2024;15(NA). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates MSU MSU ncbigene_synonym BCKDHA 593
Homo sapiens Primates TLR4 TLR4 ncbigene_symbol TLR4 7099
Homo sapiens Primates MyD88 MYD88 ncbigene_symbol MYD88 4615
Homo sapiens Primates NF-kB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates NLRP3 NLRP3 ncbigene_symbol NLRP3 114548
Homo sapiens Primates Ips IPS ncbigene_synonym SLC27A4 10999
Homo sapiens Primates Ips IPS ncbigene_synonym ISYNA1 51477
Homo sapiens Primates ADPN ADPN ncbigene_synonym ADIPOQ 9370
Homo sapiens Primates ADPN ADPN ncbigene_synonym PNPLA3 80339
Homo sapiens Primates IL-18 IL-18 ncbigene_synonym IL18 3606
Homo sapiens Primates RFS RFS ncbigene_synonym GATM 2628
Homo sapiens Primates IRF IRF ncbigene_synonym TRIM63 84676

Chemical mentions

Word Match MeSH Name ChEBI
drugs drugs chebi:23888
medicine medicine chebi:23888
acceptor Acceptor chebi:15339
acceptor Acceptor chebi:15339

Disease mentions

Word Match MeSH Name DOID